Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

National Reference Center of Keratoconus (CRNK), CHU Toulouse, France

In this page

How to contact the center

Full member

HCP Center

The National Reference Center of Keratoconus (CRNK), includes the CHUs of Bordeaux and Toulouse. Its creation is part of the logic of the development of a reference center for "rare diseases" labeled by the Ministry of Health. Since the end of 2005, the ophthalmology services of the CHUs of Bordeaux and Toulouse have been designated as national reference centers for keratoconus because of their competence previously recognized in this field.

Within the framework of this mission, corneal specialists develop a communication and care network for keratoconus whose main objectives are:


The census and epidemiological study of patients with keratoconus.
The harmonization of diagnostic and therapeutic behavior.
Development and evaluation of new care options.
Public information about this rare disease.
Dissemination of scientific knowledge about the disease.


Picture : Don-vip

Contact

National Reference Center of Keratoconus (CRNK), CHU Toulouse, France

Service d'Ophtalmologie Pavillon Dieulafoy Place du Docteur BaylacTSA 40031
31000 Toulouse
France

Team

Pr Pierre FOURNIE

Representative

France

Anterior Segment Rare Eye Diseases (WG4), Registries & Epidemiology (TWG7), Research (TWG8)
See more

Clinical trials

NCT04517903 - Completed

Validation Study on Eye Rubbing Questionnaire in Patients With or Suspected of Having a Keratoconus (KC) (QFK).

Interventional
See the trial
voir la fiche
NCT03584243 - Unknown

Transepithelial Corneal Collagen Crosslinking in Eyes With Progressive Keratoconus.

Interventional
See the trial
voir la fiche

NCT03464994 - Completed

Prevalence of Ophthalmological Abnormalities in Children and Adults Suffering From Hereditary Ichthyosis.

Interventional
See the trial
voir la fiche
NCT01756456 - Completed

Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).

Interventional
See the trial
voir la fiche
NCT03992417 - Active, Not recruiting

A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis

Observational
See the trial
voir la fiche